Krasnick, Bradley A <br/><br/>
Adjuvant therapy is associated with improved survival after curative resection for hilar cholangiocarcinoma: A multi-institution analysis from the U.S. extrahepatic biliary malignancy consortium.  [electronic resource] 

 -  Journal of surgical oncology  Mar 2018 
 - 363-371 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1096-9098 
<br/><br/><label>Standard No.: </label>10.1002/jso.24836  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Bile Duct Neoplasms--pathology<br/>Chemoradiotherapy, Adjuvant<br/>Chemotherapy, Adjuvant<br/>Cholangiocarcinoma--pathology<br/>Disease-Free Survival<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Randomized Controlled Trials as Topic<br/>Retrospective Studies<br/>Survival Rate